Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01370954 · ClinicalTrials.gov registry record
NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)
A clinical trial of Mild Cognitive Impairment and Alzheimers Disease, sponsored by Pamlab.
- Completed
- Registry status
- 204
- Enrollment target
- 1
- Study location
NCT01370954: Completed study of Mild Cognitive Impairment and Alzheimers Disease, sponsored by Pamlab.
NCT01370954 is a study of Mild Cognitive Impairment and Alzheimers Disease that has completed, run by Pamlab. The registered enrollment target is 204 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01370954, a study of Mild Cognitive Impairment and Alzheimers Disease, has completed, sponsored by Pamlab.
- COMPLETED
- Registry status
- 204 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be an observational study in which patients who have been prescribed CerefolinNAC® are invited to participate in surveys regarding their experiences with CerefolinNAC®. CerefolinNAC® is a medical food indicated for the distinct nutritional requirements of individuals under treatment for early memory loss with particular emphasis for those individuals diagnosed with or at risk for neurovascular oxidative stress and/or hyperhomocysteinemia; mild to moderate cognitive impairment with or without vitamin B12 deficiency, vascular dementia or Alzheimer's disease. The purpose of this study is to increase the understanding of the role of CerefolinNAC® in managing proper neuronal function in the brain, provide patients with personalized education and support, and contribute to the overall understanding of the needs and concerns of patients being treated for early memory loss.
Primary Outcome
The QOL-AD is a brief, 13-item measure designed specifically to obtain a rating of the patient's Quality of Life.
Conditions Studied
Interventions
- OTHER CerefolinNAC®
Study Locations (1)
North Carolina
- Falls Neurology and Memory Center - Hickory
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-12 |
What the finished NCT01370954 record still lists
NCT01370954 is an observational study that tracks outcomes without assigning an intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (84% lower).
The record links to 4 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which CerefolinNAC® is the first listed.
NCT01370954 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01370954 about?
NCT01370954 is a clinical study titled "NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)". This study will be an observational study in which patients who have been prescribed CerefolinNAC® are invited to participate in surveys regarding their experiences with CerefolinNAC®. CerefolinNAC® is a medical food indicated for the distinct nutritional requirements of individuals under treatment ...
What is the current status of trial NCT01370954?
This trial is currently completed. The enrollment target is 204 participants. The study started on 2011-05. Estimated completion is 2012-12.
What conditions does trial NCT01370954 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Alzheimers Disease, Vascular Dementia, Early Memory Loss.
What interventions are being tested in trial NCT01370954?
The interventions under investigation include: CerefolinNAC® (OTHER).
Who is sponsoring clinical trial NCT01370954?
This trial is sponsored by Pamlab, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01370954 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01370954's enrollment target sits among peer trials
204 44th of 205 higher than 162 of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
RECRUITING · Early Phase 1
-
MCI Speech in Noise
RECRUITING
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia